![Ehab Elkhouly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Ehab Elkhouly worked as an Operations Director at Response Genetics, Inc. He then worked at Cancer Genetics, Inc. as a VP-Clinical Affairs & Site Operations from 2018 to 2019.
Dr. Elkhouly has an undergraduate degree from KasrAlAiny School of Medicine and a graduate degree from Paul Merage School of Business.
Eerdere bekende functies van Ehab Elkhouly
Bedrijven | Functie | Einde |
---|---|---|
CANCER GENETICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2019 |
RESPONSE GENETICS, INC | Operationeel Directeur | - |
Opleiding van Ehab Elkhouly
KasrAlAiny School of Medicine | Undergraduate Degree |
Paul Merage School of Business | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RESPONSE GENETICS, INC | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Cancer Genetics, Inc.
![]() Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |